122 related articles for article (PubMed ID: 37097674)
1. Long-term Outcomes After Moderate Hypofractionated Proton Therapy for Centrally Located Non-small Cell Lung Cancer.
Nakamura M; Ishikawa H; Ohnishi K; Baba K; Sumiya T; Murakami M; Hiroshima Y; Mizumoto M; Okumura T; Sakurai H
Anticancer Res; 2023 May; 43(5):2003-2013. PubMed ID: 37097674
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated proton beam therapy for centrally located lung cancer.
Nakamura N; Hotta K; Zenda S; Baba H; Kito S; Akita T; Motegi A; Hojo H; Nakamura M; Parshuram RV; Okumura M; Akimoto T
J Med Imaging Radiat Oncol; 2019 Aug; 63(4):552-556. PubMed ID: 31145553
[TBL] [Abstract][Full Text] [Related]
3. Proton Beam Therapy in Elderly Patients With cT1-3N0M0 Non-small Cell Lung Cancer.
Nakamura M; Ishikawa H; Ohnishi K; Baba K; Saito T; Sumiya T; Murakami M; Hiroshima Y; Nakai K; Mizumoto M; Okumura T; Sakurai H
Anticancer Res; 2022 Jun; 42(6):2953-2960. PubMed ID: 35641259
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease.
Saito T; Ohnishi K; Ishikawa H; Nakamura M; Hoshiai S; Numajiri H; Murofushi KN; Mizumoto M; Okumura T; Sakurai H
Anticancer Res; 2021 Nov; 41(11):5635-5642. PubMed ID: 34732436
[TBL] [Abstract][Full Text] [Related]
5. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer.
Kanemoto A; Okumura T; Ishikawa H; Mizumoto M; Oshiro Y; Kurishima K; Homma S; Hashimoto T; Ohkawa A; Numajiri H; Ohno T; Moritake T; Tsuboi K; Sakae T; Sakurai H
Clin Lung Cancer; 2014 Mar; 15(2):e7-12. PubMed ID: 24365049
[TBL] [Abstract][Full Text] [Related]
7. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
[TBL] [Abstract][Full Text] [Related]
8. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer.
Bayasgalan U; Moon SH; Jeong JH; Kim TH; Cho KH; Suh YG
Radiat Oncol; 2021 Aug; 16(1):155. PubMed ID: 34407855
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
[TBL] [Abstract][Full Text] [Related]
12. High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Azami Y; Kato T; Tsukiyama I; Hareyama M; Kikuchi Y; Daimon T; Hata M; Inoue T; Fuwa N
Acta Oncol; 2015 Mar; 54(3):307-14. PubMed ID: 25291076
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated three-dimensional conformal radiation therapy alone for centrally located cT1-3N0 non-small-cell lung cancer.
Oh D; Ahn YC; Kim B; Pyo H
J Thorac Oncol; 2013 May; 8(5):624-9. PubMed ID: 23584294
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
[TBL] [Abstract][Full Text] [Related]
15. High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center.
Bush DA; Cheek G; Zaheer S; Wallen J; Mirshahidi H; Katerelos A; Grove R; Slater JD
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):964-8. PubMed ID: 23845845
[TBL] [Abstract][Full Text] [Related]
16. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.
Volpe S; Piperno G; Colombo F; Biffi A; Comi S; Mastroleo F; Maria Camarda A; Casbarra A; Cattani F; Corrao G; de Marinis F; Spaggiari L; Guckenberger M; Orecchia R; Alterio D; Jereczek-Fossa BA
Cancer Treat Rev; 2022 Nov; 110():102464. PubMed ID: 36194908
[TBL] [Abstract][Full Text] [Related]
18. Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancer.
Kharod SM; Nichols RC; Henderson RH; Morris CG; Pham DC; Seeram VK; Jones LM; Antonio-Miranda M; Huh S; Li Z; Hoppe BS
Acta Oncol; 2020 Oct; 59(10):1164-1170. PubMed ID: 32394776
[TBL] [Abstract][Full Text] [Related]
19. Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer.
Nakamura M; Ishikawa H; Ohnishi K; Mori Y; Baba K; Nakazawa K; Shiozawa T; Sekine I; Maruo K; Okumura T; Sakurai H
J Radiat Res; 2023 Mar; 64(2):438-447. PubMed ID: 36592478
[TBL] [Abstract][Full Text] [Related]
20. Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer.
Ono T; Nakamura T; Yamaguchi H; Azami Y; Takayama K; Suzuki M; Wada H; Kikuchi Y; Murakami M; Nemoto K
Radiat Oncol; 2018 Feb; 13(1):19. PubMed ID: 29402290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
